128 related articles for article (PubMed ID: 38505619)
21. EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.
Tan X; Xiao GY; Wang S; Shi L; Zhao Y; Liu X; Yu J; Russell WK; Creighton CJ; Kurie JM
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36757799
[TBL] [Abstract][Full Text] [Related]
22. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity.
Gu Y; Lin X; Dong Y; Wood G; Seidah NG; Werstuck G; Major P; Bonert M; Kapoor A; Tang D
J Exp Clin Cancer Res; 2023 Jan; 42(1):2. PubMed ID: 36588164
[TBL] [Abstract][Full Text] [Related]
23. Comparison of cell type distribution between single-cell and single-nucleus RNA sequencing: enrichment of adherent cell types in single-nucleus RNA sequencing.
Oh JM; An M; Son DS; Choi J; Cho YB; Yoo CE; Park WY
Exp Mol Med; 2022 Dec; 54(12):2128-2134. PubMed ID: 36460793
[TBL] [Abstract][Full Text] [Related]
24. A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma.
Zhang C; Shen H; Yang T; Li T; Liu X; Wang J; Liao Z; Wei J; Lu J; Liu H; Xiang L; Yang Y; Yang M; Wang D; Li Y; Xing R; Teng S; Zhao J; Yang Y; Zhao G; Chen K; Li X; Yang J
Nat Commun; 2022 Nov; 13(1):7250. PubMed ID: 36433984
[TBL] [Abstract][Full Text] [Related]
25. Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity.
Kennel KB; Bozlar M; De Valk AF; Greten FR
Clin Cancer Res; 2023 Mar; 29(6):1009-1016. PubMed ID: 36399325
[TBL] [Abstract][Full Text] [Related]
26. Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8
Chen W; Teo JMN; Yau SW; Wong MY; Lok CN; Che CM; Javed A; Huang Y; Ma S; Ling GS
Cell Rep; 2022 Nov; 41(7):111647. PubMed ID: 36384131
[TBL] [Abstract][Full Text] [Related]
27. Single-cell RNA-seq uncovers cellular heterogeneity and provides a signature for paediatric sleep apnoea.
Cortese R; Adams TS; Cataldo KH; Hummel J; Kaminski N; Kheirandish-Gozal L; Gozal D
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36356973
[TBL] [Abstract][Full Text] [Related]
28. miR-181d-5p Protects against Retinal Ganglion Cell Death after Blunt Ocular Injury by Regulating NFIA-Medicated Astrocyte Development.
Li J; Liu J; Zhang Y; Zha X; Zhang H; Tang Y; Zhao X
Mediators Inflamm; 2022; 2022():5400592. PubMed ID: 36254157
[TBL] [Abstract][Full Text] [Related]
29. Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma.
Patterson A; Auslander N
Nat Commun; 2022 Sep; 13(1):5151. PubMed ID: 36123351
[TBL] [Abstract][Full Text] [Related]
30. A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy.
Li X; He Y; Wu J; Qiu J; Li J; Wang Q; Jiang Y; Han J
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 36063561
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response.
Zhang Z; Wang ZX; Chen YX; Wu HX; Yin L; Zhao Q; Luo HY; Zeng ZL; Qiu MZ; Xu RH
Genome Med; 2022 Apr; 14(1):45. PubMed ID: 35488273
[TBL] [Abstract][Full Text] [Related]
32. The combination of PD-1 blockade with interferon-α has a synergistic effect on hepatocellular carcinoma.
Zhu Y; Chen M; Xu D; Li TE; Zhang Z; Li JH; Wang XY; Yang X; Lu L; Jia HL; Dong QZ; Qin LX
Cell Mol Immunol; 2022 Jun; 19(6):726-737. PubMed ID: 35459855
[TBL] [Abstract][Full Text] [Related]
33. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.
Arnold M; Singh D; Laversanne M; Vignat J; Vaccarella S; Meheus F; Cust AE; de Vries E; Whiteman DC; Bray F
JAMA Dermatol; 2022 May; 158(5):495-503. PubMed ID: 35353115
[TBL] [Abstract][Full Text] [Related]
34. Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer.
Obradovic A; Graves D; Korrer M; Wang Y; Roy S; Naveed A; Xu Y; Luginbuhl A; Curry J; Gibson M; Idrees K; Hurley P; Jiang P; Liu XS; Uppaluri R; Drake CG; Califano A; Kim YJ
Clin Cancer Res; 2022 May; 28(10):2094-2109. PubMed ID: 35262677
[TBL] [Abstract][Full Text] [Related]
35. Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.
Rosa FF; Pires CF; Kurochkin I; Halitzki E; Zahan T; Arh N; Zimmermannová O; Ferreira AG; Li H; Karlsson S; Scheding S; Pereira CF
Sci Immunol; 2022 Mar; 7(69):eabg5539. PubMed ID: 35245086
[TBL] [Abstract][Full Text] [Related]
36. Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response.
He J; Xiong X; Yang H; Li D; Liu X; Li S; Liao S; Chen S; Wen X; Yu K; Fu L; Dong X; Zhu K; Xia X; Kang T; Bian C; Li X; Liu H; Ding P; Zhang X; Liu Z; Li W; Zuo Z; Zhou P
Cell Res; 2022 Jun; 32(6):530-542. PubMed ID: 35165422
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma.
Song P; Li W; Wu X; Qian Z; Ying J; Gao S; He J
Cancer Immunol Immunother; 2022 Oct; 71(10):2341-2354. PubMed ID: 35152302
[TBL] [Abstract][Full Text] [Related]
38. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.
Vanhersecke L; Brunet M; Guégan JP; Rey C; Bougouin A; Cousin S; Moulec SL; Besse B; Loriot Y; Larroquette M; Soubeyran I; Toulmonde M; Roubaud G; Pernot S; Cabart M; Chomy F; Lefevre C; Bourcier K; Kind M; Giglioli I; Sautès-Fridman C; Velasco V; Courgeon F; Oflazoglu E; Savina A; Marabelle A; Soria JC; Bellera C; Sofeu C; Bessede A; Fridman WH; Loarer FL; Italiano A
Nat Cancer; 2021 Aug; 2(8):794-802. PubMed ID: 35118423
[TBL] [Abstract][Full Text] [Related]
39. Pan-cancer single-cell landscape of tumor-infiltrating T cells.
Zheng L; Qin S; Si W; Wang A; Xing B; Gao R; Ren X; Wang L; Wu X; Zhang J; Wu N; Zhang N; Zheng H; Ouyang H; Chen K; Bu Z; Hu X; Ji J; Zhang Z
Science; 2021 Dec; 374(6574):abe6474. PubMed ID: 34914499
[TBL] [Abstract][Full Text] [Related]
40. Multi-omic machine learning predictor of breast cancer therapy response.
Sammut SJ; Crispin-Ortuzar M; Chin SF; Provenzano E; Bardwell HA; Ma W; Cope W; Dariush A; Dawson SJ; Abraham JE; Dunn J; Hiller L; Thomas J; Cameron DA; Bartlett JMS; Hayward L; Pharoah PD; Markowetz F; Rueda OM; Earl HM; Caldas C
Nature; 2022 Jan; 601(7894):623-629. PubMed ID: 34875674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
